We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IMB:LSEImperial Brands PLC Analysis

Data as of 2026-09-01 - not real-time

£2,551.00

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Imperial Brands PLC is priced at £2,551.00 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 10.3% over the past 30 days. Momentum indicators put RSI at 40.4 (neutral) with MACD reading bearish. Price has been bracketed by support at £2,476.00 and resistance at £2,799.00.
On valuation the read is undervalued — an earnings multiple of 12.0, absent a reliable peer benchmark. Sell-side targets cluster 29.0% above the current quote. Revenue is growing at 4.9% on a 9.0% profit margin. The 6.60% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 24.6%, a beta of -0.06 and a maximum drawdown of 25.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Imperial Brands PLC, a leading tobacco company, continues to navigate regulatory pressures and shiftImperial Brands is back in focus after its fair value estimate was trimmed from £34.Imperial Brands PLC shares continue to trade in a narrow range on the London Stock Exchange, with in

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 2956.87
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 2956.87
  • Analyst targets imply +29.0% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +29.0% versus the current price
  • P/E ratio of 12.0
  • Return on equity of 37.2%

Key Metrics & Analysis

Financial Health

Revenue Growth4.90%
Profit Margin8.96%
P/E Ratio12.0
ROE37.15%
ROA7.80%
Debt/Equity243.80
P/B Ratio5.0
Op. Cash Flow£3.5B
Free Cash Flow£2.5B

Technical Analysis

TrendBearish
RSI40.4
Support£2,476.00
Resistance£2,799.00
MA 20£2,603.65
MA 50£2,715.28
MA 200£2,956.87
MACDBearish
VolumeDecreasing
Fear & Greed Index94.21

Valuation

Fair Value£3,770.25
Target Price£3,290.91
Upside/Downside29.00%
GradeUndervalued
TypeBlend
Dividend Yield6.60%

Risk Assessment

Beta-0.06
Volatility24.60%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.